# Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

> **NCT00209742** · PHASE3 · UNKNOWN · sponsor: **Hokkaido Gastrointestinal Cancer Study Group** · enrollment: 340 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** UFT
- **DRUG:** USEL/Leucovorin
- **DRUG:** Krestin

## Key facts

- **NCT ID:** NCT00209742
- **Lead sponsor:** Hokkaido Gastrointestinal Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2010-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209742, "Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00209742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*